fda warning letters compounded semaglutide tirzepatide september 2025 GLP-1 Compounding: When Innovation May Mean Liability FDA Takes Aim at Hims

PMID: 15976791, PMCID: PMC2790272, DOI: 10.1016/j.ahj.2004.08.018

, -1

HA may serve as a common underlying mechanism for the co-occurrence of PCOS and MS (Zeng et al., 2020

Salonia, A

Abbreviations AEs: Adverse events NAEs: Neurological adverse events FDA: The Food and Drug Administration FAERS: The FDA Adverse Event Reporting System GLP-1 RAs: Glucagon-like peptide-1 receptor agonists ADRs: Adverse drug reactions PTs: Preferred Terms SOCs: System Organ Classes IQR: Interquartile range ROR: Reporting odds ratio CI: Confidence interval PRR: Proportional reporting ratio BCPNN: Bayesian Confidence Propagation Neural Network EBGM: Empirical Bayesian geometric mean EBGM05: The lower limit of 95% CI of EBGM IC: Information component IC025: The lower limit of 95% CI of the IC VANs: Vagal afferent neurons T2DM: Type 2 diabetes mellitus OR: Odds ratios References Targher, G., Mantovani, A